Pharmacokinetic drug interactions involving vortioxetine (Lu AA21004), a multimodal antidepressant
about
Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literatureThe safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies.Vortioxetine: a New Treatment for Major Depressive Disorder.Population pharmacokinetic meta-analysis of vortioxetine in healthy individualsVortioxetine in the treatment of adult patients with major depressive disorder: a meta-analysis of randomized double-blind controlled trialsLack of Effect of Vortioxetine on the Pharmacokinetics and Pharmacodynamics of Ethanol, Diazepam, and Lithium.New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder.Vortioxetine for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?Vortioxetine for the treatment of depression.Vortioxetine: a review of its use in major depressive disorder.Vortioxetine for the treatment of major depressive disorder.The efficacy of vortioxetine for the treatment of major depressive disorder.Vortioxetine : a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder.Pharmacotherapy of major depression in late life: what is the role of new agents?Vortioxetine: Clinical Pharmacokinetics and Drug Interactions.Pharmacokinetics, Safety, and Tolerability of Vortioxetine Following Single- and Multiple-Dose Administration in Healthy Japanese Adults.The efficacy and safety of 5 mg/d Vortioxetine compared to placebo for major depressive disorder: A meta-analysis.Vortioxetine: first global approval.HILIC-MS Determination of Genotoxic Impurity of 2-Chloro-N-(2-Chloroethyl)Ethanamine in the Vortioxetine Manufacturing Process.Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo
P2860
Q26796436-A1401F24-5D3D-4F3A-B977-712AB643C203Q31044175-57415816-08F3-4671-8ACC-0BAA814960AEQ34505568-61EE9BA1-DA81-44C8-B016-EBFFC6DC1664Q34639656-FE1B8899-61B5-4851-BCAB-FDDCDE953DD0Q35280477-CD9C8FA0-A03A-4B9D-9094-A18CBFAE545CQ37201637-C59F977E-4C9D-4622-BA91-7D414E0CB661Q37601281-A94295E0-5B2D-433E-A791-B2F03399E30BQ38156001-DD362566-E6F4-4D13-BDC6-0DB632ECEE41Q38199987-A9633E6C-6403-4A2B-A26F-9B14B665B8AFQ38242001-4B0BB6D3-91DD-4ED7-BDEE-947E98B874F1Q38244159-3B9C3979-7500-4C98-9F76-6500FCC0DD98Q38270790-B9486298-9D6F-4441-95B3-6168CA3F8EE1Q38506798-10AF1A52-B60B-4D3E-BF5B-539B75FE544EQ38894956-41466678-32A4-4C12-B946-741C21085968Q47692041-0CC72A2F-B13C-489A-BAE4-F6A3302BB72DQ47760557-10208A25-BAE3-4DD4-BA7E-79D1AF1F889CQ48285675-8B76EF51-19BA-4499-90F4-AF69741E62CCQ48390325-4CAEFADC-952C-4CA3-A4C2-50765E5A2605Q48970882-A99E5291-544F-4365-99C5-C7FF51FAE2F3Q58736541-FA3095A6-49A0-4A58-BC4D-FBE118A6976A
P2860
Pharmacokinetic drug interactions involving vortioxetine (Lu AA21004), a multimodal antidepressant
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic drug interacti ...... ), a multimodal antidepressant
@en
Pharmacokinetic drug interacti ...... , a multimodal antidepressant.
@nl
type
label
Pharmacokinetic drug interacti ...... ), a multimodal antidepressant
@en
Pharmacokinetic drug interacti ...... , a multimodal antidepressant.
@nl
prefLabel
Pharmacokinetic drug interacti ...... ), a multimodal antidepressant
@en
Pharmacokinetic drug interacti ...... , a multimodal antidepressant.
@nl
P2093
P2860
P1476
Pharmacokinetic drug interacti ...... ), a multimodal antidepressant
@en
P2093
Astrid-Maria Højer
Grace Chen
Jeppe Klint Buchbjerg
Michael Serenko
Ronald Lee
P2860
P304
P356
10.1007/S40261-013-0117-6
P577
2013-10-01T00:00:00Z